(Q36609811)

15 August 2017

1 reference

title

Treatment of cutaneous T-cell lymphoma with retinoids (English)

1 reference

15 August 2017

Chunlei Zhang

1

1 reference

PubMed ID

17014481

15 August 2017

Madeleine Duvic

series ordinal

2

1 reference

15 August 2017

1 September 2006

1 reference

15 August 2017

1 reference

15 August 2017

19

1 reference

15 August 2017

5

1 reference

15 August 2017

264-271

1 reference

Cutaneous T-cell lymphoma: epidemiology, etiology, and classification

15 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00083.X

The changing survival of patients with mycosis fungoides: a population-based assessment of trends in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00083.X

Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00083.X

Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00083.X

Aberrant Cytokine Production By Sezary Syndrome Patients: Cytokine Secretion Pattern Resembles Murine Th2 Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00083.X

Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma. Reduced proliferation and preferential secretion of a T helper-2-like cytokine pattern on stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00083.X

Isotretinoin in cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00083.X

The effect of isotretinoin in six patients with cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00083.X

Follicular cutaneous T-cell lymphoma: beneficial effect of isotretinoin for persisting cysts and comedones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00083.X

CD40 activation of BCP-ALL cells generates IL-10-producing, IL-12-defective APCs that induce allogeneic T-cell anergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00083.X

Optimizing bexarotene therapy for cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00083.X

Comparison of selective retinoic acid receptor- and retinoic X receptor-mediated efficacy, tolerance, and survival in cutaneous t-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00083.X

Phase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00083.X

Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00083.X

Topical targretin and intralesional interferon alfa for cutaneous lymphoma of the scalp

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00083.X

Bexarotene reverses alopecia in cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00083.X

Bexarotene is a new treatment option for lymphomatoid papulosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00083.X

Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00083.X

Cutaneous T-cell lymphoma treatment using bexarotene and PUVA: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00083.X

Management of refractory early-stage cutaneous T-cell lymphoma (mycosis fungoides) with a combination of oral bexarotene and psoralen plus ultraviolet bath therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00083.X

Low-dose oral bexarotene in combination with low-dose interferon alfa in the treatment of cutaneous T-cell lymphoma: clinical synergism and possible immunologic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00083.X

Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00083.X

Immunomodulatory effects of RXR rexinoids: modulation of high-affinity IL-2R expression enhances susceptibility to denileukin diftitox

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00083.X

Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00083.X

Activation of retinoid X receptors induces apoptosis in HL-60 cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00083.X

The novel synthetic oleanane triterpenoid CDDO (2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid) induces apoptosis in Mycosis fungoides/Sézary syndrome cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2006.00083.X

10.1111/J.1529-8019.2006.00083.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17014481